- Home
- VNDA vs OSUR Comparison
VNDA vs OSUR Comparison
Compare VNDA & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- OSUR
- Stock Information
- Founded
- VNDA 2002
- OSUR 2000
- Country
- VNDA United States
- OSUR United States
- Employees
- VNDA N/A
- OSUR N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- VNDA Health Care
- OSUR Health Care
- Exchange
- VNDA Nasdaq
- OSUR Nasdaq
- Market Cap
- VNDA 282.8M
- OSUR 266.7M
- IPO Year
- VNDA 2006
- OSUR 1986
- Fundamental
- Price
- VNDA $4.77
- OSUR $3.44
- Analyst Decision
- VNDA Strong Buy
- OSUR Hold
- Analyst Count
- VNDA 2
- OSUR 2
- Target Price
- VNDA $16.50
- OSUR $5.50
- AVG Volume (30 Days)
- VNDA 652.5K
- OSUR 1.0M
- Earning Date
- VNDA 05-07-2025
- OSUR 05-07-2025
- Dividend Yield
- VNDA N/A
- OSUR N/A
- EPS Growth
- VNDA N/A
- OSUR N/A
- EPS
- VNDA N/A
- OSUR N/A
- Revenue
- VNDA $198,772,000.00
- OSUR $185,827,000.00
- Revenue This Year
- VNDA $14.36
- OSUR N/A
- Revenue Next Year
- VNDA $44.53
- OSUR $8.41
- P/E Ratio
- VNDA N/A
- OSUR N/A
- Revenue Growth
- VNDA 3.18
- OSUR N/A
- 52 Week Low
- VNDA $3.71
- OSUR $2.69
- 52 Week High
- VNDA $6.75
- OSUR $6.69
- Technical
- Relative Strength Index (RSI)
- VNDA 48.67
- OSUR 45.82
- Support Level
- VNDA $4.84
- OSUR $3.40
- Resistance Level
- VNDA $5.04
- OSUR $3.55
- Average True Range (ATR)
- VNDA 0.22
- OSUR 0.15
- MACD
- VNDA -0.01
- OSUR 0.02
- Stochastic Oscillator
- VNDA 26.32
- OSUR 56.52
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.